Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New compound could give some types of cancer the one-two punch

23.08.2004


Ohio State University researchers are working on developing a multi-purpose cancer drug that might one day scale back the number of medications some cancer patients need to take.



In laboratory tests, a dual-action compound called OSU 111 has shown promise in killing prostate cancer cells. "It had a direct toxic effect on cancer cells, and also prevented angiogenesis – the formation of new blood vessels from pre-existing ones," said Tom Li, the study’s lead investigator and an associate professor of pharmacy at Ohio State. "It’s like using one stone to kill two birds."

Li presented the results on August 22 in Philadelphia at the summer meeting of the American Chemical Society.


OSU 111 is a variation on a theme – Li and his colleagues created OSU 111 using a known anti-cancer compound, SU-5416, as a model. Although SU-5416 showed promise in preclinical studies, it did not have the kind of far-reaching effectiveness that researchers had hoped for.

But SU-5416 does provide a good blueprint by which researchers can create dozens of analogs – compounds structurally similar, but with slightly different chemical compositions. "We’ve made close to 50 different analogs by modifying SU-5416," Li said.

Laboratory experiments show that OSU 111 is one of the most promising analogs for killing cancer cells Li’s team has found so far. When treated with OSU 111 in laboratory experiments, the majority of prostate cancer tissue cells died within three days, Li said. "This compound stopped cell division in its tracks," he said.

OSU 111 induces apoptosis – cell suicide – in cancer cells because it keeps key structures called microtubules from working during cell division. Microtubules distribute chromosomes to new cells. OSU 111 also prevents tumor cells from forming new blood vessels.

Scientists are looking for alternatives to established anti-cancer drugs, such as Taxol, which is used to kill cancer cells in ovarian, breast and lung tissue. Drugs like Taxol come from natural sources, and supplies are sometimes extremely limited. Also, synthetic versions of these drugs can be very difficult to make.

Providing a drug with more than one effect could also benefit cancer patients who are inundated with medications.

"Many clinical trials that test new cancer treatments use a combination of drugs – one to prevent the growth of new blood vessels, for example, and another to keep cancer cells from dividing and spreading," Li said. "One drug with dual activity means that the body only has to deal with a single compound, and that could eliminate a lot of complexity in terms of giving medication to patients, the body’s ability to absorb a drug and also side effects.

"We want to find a drug with a dual purpose," he continued. "Angiogenesis is very prominent in many cancers, particularly prostate cancer. Pure anti-angiogenic compounds haven’t been that successful; somehow cancer cells still find a way to form blood vessels."

Li and his colleagues are continuing to look for even more potent analogs based on the structure of SU-5416. "We’re developing small, easy-to-make compounds that are similar to established drugs, but hopefully much easier to come by," he said.

Li conducted this work with Ohio State colleagues Bulbul Pandit, Zhigen Hu, Zili Xiao and Christine Cheah; and Dan Sackett, of the Laboratory of Integrative and Medical Biophysics at the National Institute of Child Health and Human Development.

Tom Li | EurekAlert!
Further information:
http://www.osu.edu

More articles from Health and Medicine:

nachricht NIST scientists discover how to switch liver cancer cell growth from 2-D to 3-D structures
17.11.2017 | National Institute of Standards and Technology (NIST)

nachricht High speed video recording precisely measures blood cell velocity
15.11.2017 | ITMO University

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: A “cosmic snake” reveals the structure of remote galaxies

The formation of stars in distant galaxies is still largely unexplored. For the first time, astron-omers at the University of Geneva have now been able to closely observe a star system six billion light-years away. In doing so, they are confirming earlier simulations made by the University of Zurich. One special effect is made possible by the multiple reflections of images that run through the cosmos like a snake.

Today, astronomers have a pretty accurate idea of how stars were formed in the recent cosmic past. But do these laws also apply to older galaxies? For around a...

Im Focus: Visual intelligence is not the same as IQ

Just because someone is smart and well-motivated doesn't mean he or she can learn the visual skills needed to excel at tasks like matching fingerprints, interpreting medical X-rays, keeping track of aircraft on radar displays or forensic face matching.

That is the implication of a new study which shows for the first time that there is a broad range of differences in people's visual ability and that these...

Im Focus: Novel Nano-CT device creates high-resolution 3D-X-rays of tiny velvet worm legs

Computer Tomography (CT) is a standard procedure in hospitals, but so far, the technology has not been suitable for imaging extremely small objects. In PNAS, a team from the Technical University of Munich (TUM) describes a Nano-CT device that creates three-dimensional x-ray images at resolutions up to 100 nanometers. The first test application: Together with colleagues from the University of Kassel and Helmholtz-Zentrum Geesthacht the researchers analyzed the locomotory system of a velvet worm.

During a CT analysis, the object under investigation is x-rayed and a detector measures the respective amount of radiation absorbed from various angles....

Im Focus: Researchers Develop Data Bus for Quantum Computer

The quantum world is fragile; error correction codes are needed to protect the information stored in a quantum object from the deteriorating effects of noise. Quantum physicists in Innsbruck have developed a protocol to pass quantum information between differently encoded building blocks of a future quantum computer, such as processors and memories. Scientists may use this protocol in the future to build a data bus for quantum computers. The researchers have published their work in the journal Nature Communications.

Future quantum computers will be able to solve problems where conventional computers fail today. We are still far away from any large-scale implementation,...

Im Focus: Wrinkles give heat a jolt in pillared graphene

Rice University researchers test 3-D carbon nanostructures' thermal transport abilities

Pillared graphene would transfer heat better if the theoretical material had a few asymmetric junctions that caused wrinkles, according to Rice University...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Ecology Across Borders: International conference brings together 1,500 ecologists

15.11.2017 | Event News

Road into laboratory: Users discuss biaxial fatigue-testing for car and truck wheel

15.11.2017 | Event News

#Berlin5GWeek: The right network for Industry 4.0

30.10.2017 | Event News

 
Latest News

Antarctic landscape insights keep ice loss forecasts on the radar

20.11.2017 | Earth Sciences

Filling the gap: High-latitude volcanic eruptions also have global impact

20.11.2017 | Earth Sciences

Water world

20.11.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>